Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New cocktail of charcoal and laxative could flush out poisons faster

NCT ID NCT07201311

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 36 times

Summary

This study tests whether giving a combination of activated charcoal and polyethylene glycol (a laxative) can reduce the amount of poison absorbed in people who have taken a severe overdose of certain drugs and are in intensive care. The trial will include 200 adults who need a breathing tube. The goal is to see if this treatment lowers the poison level in the blood more than standard care with charcoal alone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEVERE POISONING WITH CARDIOTROPIC OR PSYCHOTROPIC DRUG are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Sebastian Voicu

    Paris, 75010, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

activated charcoal and polyethylene glycol

What this could lead to

If it works, this could provide a more effective way to remove toxins from the body in severe poisoning cases, potentially reducing complications.

What could go wrong

This is an early phase 2 trial with only 200 participants, so results may not apply broadly. The treatment may not significantly lower toxin levels or could cause side effects like bowel issues.

Conditions

The condition(s) this trial relates to.

anthrax infection poisoning

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.